A study to find out if people get the same amount of medicine (alectinib) - when they take different forms of the medicine - with or without food.
A randomized, open-label, two-treatment, two-part, study to explore the performance of alectinib extemporaneous suspension on alectinib capsule bioavailability in healthy subjects in fed and fasted conditions.
Healthy Volunteers
Basic Details
This clinical trial was done to study a medicine called, “alectinib”, for the treatment of patients with cancer. This study investigated how much medicine was available in the body (relative bioavailability) in different formulations - when alectinib was taken as an oral suspension and as hard capsules - taken without food (Group 1) and with food (Group 2). Twenty-eight healthy people took part in this study in one country.
The source of the below information is public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc.. It has been summarised and edited into simpler language. For more information about this clinical study see the For Expert tab on the specific ForPatients page or follow these links to https://clinicaltrials.gov and/or https://euclinicaltrials.eu and/or https://www.isrctn.com.
The information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc., and has not been edited.
Results Disclaimer
For the latest version of this information please go to www.forpatients.roche.com